Eko Analysis Software vs AVIEW Lung Nodule CAD
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if you need an FDA-cleared AI solution for real-time, point-of-care cardiovascular disease detection using digital stethoscopes. This tool is ideal for clinicians seeking to quickly screen for heart murmurs and atrial fibrillation during physical exams or facilitate remote auscultation via telehealth. It allows for easy recording, playback, and secure cloud storage of heart sounds and ECGs for ongoing patient management.
View Eko Analysis Software →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your practice requires advanced AI assistance for comprehensive analysis of chest CT scans. This software is best suited for radiologists focused on lung cancer screening and detailed pulmonary nodule management, offering features like 3D volume quantification, Lung-RADS classification, and nodule follow-up comparisons. It also provides simultaneous quantitative analysis for emphysema and coronary artery calcification, enabling a holistic thoracic health assessment.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | AVIEW Lung Nodule CAD |
|---|---|---|
| Deployment | Unknown | On-premises and cloud environment |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with digital stethoscopes and a mobile app, making it highly accessible and intuitive for a broader range of frontline clinicians at the point of care. Its design for mobile use and integration with a familiar tool like the stethoscope lowers the barrier to adoption, with recent app updates focused on improving the user experience.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value in their respective specialties. Eko Analysis Software provides crucial early detection of heart murmurs and AFib at the point of care with high accuracy. AVIEW Lung Nodule CAD offers comprehensive, multi-disease analysis for radiologists from CT scans, improving efficiency and accuracy in lung cancer screening, COPD, and coronary artery calcification.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software employs a transparent freemium model, allowing users to access basic features for free and subscribe for advanced AI capabilities, with pricing details available within the app. In contrast, AVIEW Lung Nodule CAD's pricing is not publicly disclosed, making it difficult for potential customers to assess its value without direct engagement.
Enterprise Readiness
AVIEW Lung Nodule CADAVIEW Lung Nodule CAD offers significantly more flexible deployment options, including cloud-based, hybrid, locally on dedicated hardware, and locally virtualized solutions, catering to diverse enterprise IT environments. It also explicitly supports integration with PACS and RIS via DICOM and HL7 standards. While Eko is cloud-based and offers enterprise solutions, its deployment flexibility is not as extensive.
Innovation
TieBoth tools showcase significant innovation. Eko Analysis Software innovates by bringing FDA-cleared AI for cardiac disease detection to the point of care through digital stethoscopes, transforming a traditional tool into an objective screening device. AVIEW Lung Nodule CAD's innovation lies in its comprehensive 'Big 3' simultaneous analysis of lung nodules, emphysema, and coronary artery calcification from a single CT scan, offering a holistic diagnostic approach.
Support & Docs
Eko Analysis SoftwareEko provides a more transparent and accessible range of support options, including email, phone support (with scheduled calls), a comprehensive help center with FAQs and user manuals, and live Q&A sessions. Eko also publishes an enterprise support desk SLA with defined hours and response times. Coreline Soft offers standard contact methods but less publicly detailed support documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | AVIEW Lung Nodule CAD |
|---|---|---|
| Name | Eko Analysis Software | AVIEW Lung Nodule CAD |
| Company | Eko Devices | Coreline Soft Co. |
| Description | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. | AI-powered software by Coreline Soft Co. that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification. |
| Primary Clinical Focus | Cardiovascular disease detection (heart murmurs, atrial fibrillation) | Pulmonary nodule detection and analysis, lung cancer screening, COPD, and coronary artery calcification |
| Key Feature 1 | FDA-cleared AI for heart murmur detection | AI-based pulmonary nodule detection (3-20 mm) on CT scans |
| Key Feature 2 | FDA-cleared AI for atrial fibrillation (AFib) detection | Nodule classification (solid, part-solid, non-solid) |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and AVIEW Lung Nodule CAD.